Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer

被引:19
|
作者
Kim, Josephine S. [1 ,2 ]
Mills, Kathryn A. [1 ,2 ]
Fehniger, Julia [1 ,2 ]
Liao, Chuanhong [3 ]
Hurteau, Jean A. [2 ]
Kirschner, Carolyn V. [2 ]
Lee, Nita K. [1 ]
Rodriguez, Gustavo C. [2 ]
Yamada, S. Diane [1 ]
Moore, Elena S. Diaz [2 ]
Tenney, Meaghan E. [1 ]
机构
[1] Univ Chicago Med, Dept Obstet & Gynecol, Sect Gynecol Oncol, Chicago, IL USA
[2] NorthShore Univ HealthSyst, Dept Obstet & Gynecol, Div Gynecol Oncol, Evanston, IL USA
[3] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA
关键词
endometrial cancer; venous thromboembolism; robotic hysterectomy; MINIMALLY INVASIVE SURGERY; GYNECOLOGIC-ONCOLOGY; WOMEN; HYSTERECTOMY; PREVENTION; SOCIETY; RISK;
D O I
10.1097/IGC.0000000000001084
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: This study aims to determine the rate of postoperative venous thromboembolism (VTE) in endometrial cancer patients undergoing robotic hysterectomy with or without extended pharmacologic VTE prophylaxis. Methods/Materials: A retrospective chart review of women undergoing robotic hysterectomy with or without other procedures for endometrial cancer from January 2010 to February 2015 was conducted at 2 institutions. Charts were manually abstracted, and rates of VTE within 30 and 60 days after surgery were determined. Patients were then stratified by those who did and did not receive extended VTE prophylaxis. Results: A total of 403 patients were included, of which 367 patients (91%) received extended pharmacologic prophylaxis and 36 patients (9%) did not. Low molecular weight heparin prescriptions ranged from 7 to 30 days. Patients receiving extended prophylaxis (EP) were older (63 +/- 11 vs 57 +/- 12; P = 0.004), more frequently underwent lymphadenectomy (67% vs 34%; P G 0.001), and had higher-grade tumors compared with patients not receiving EP. Overall 30-day and 60-day VTE rates were 0.7% and 1.2%, respectively. There were no significant differences in 30-day and 60-day VTE rates among patients that did and did not receive EP, although a trend toward lower VTE rates in the EP group was observed (30-day rates 0.5% vs 2.8% respectively, P = 0.25; 60-day rates 0.8% vs 5.6%, P = 0.07). Conclusions: In this study, 30-day and 60-day VTE rates after minimally invasive surgery for endometrial cancer were low. Rates were also similar to those of previous reports in this setting in which the majority of patients did not receive extended VTE prophylaxis. Given the consistent finding that postoperative VTE in this population is rare regardless of prophylaxis use and the variability in practice patterns for VTE prophylaxis, the development of best practice guidelines for EP use specific to this setting is warranted.
引用
收藏
页码:1774 / 1782
页数:9
相关论文
共 50 条
  • [1] Venous thromboembolism in patients receiving extended pharmacologic prophylaxis following robotic surgery for endometrial cancer
    Kim, J.
    Mills, K.
    Fehniger, J.
    Diaz, E.
    Febbraro, T.
    Yamada, S. D.
    Lee, N.
    Tenney, M.
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 187 - 187
  • [2] Extended Venous Thromboembolism Prophylaxis after Robotic Staging for Endometrial Cancer
    Palmieri, Alicia
    Hicks, Verda
    Aikman, Noelle
    Borowsky, Mark
    Haggerty, Ashley
    Elsahwi, Karim
    [J]. SOUTHERN MEDICAL JOURNAL, 2023, 116 (10) : 790 - 794
  • [3] The role of extended prophylaxis for venous thromboembolism in patients undergoing minimally invasive surgery for endometrial cancer
    Tenney, M. E.
    Ham, S. A.
    Lee, N. K.
    Febbraro, T.
    Steppacher, R.
    Yamada, S. D.
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 186 - 186
  • [4] Hospital Variation in Extended Venous Thromboembolism Prophylaxis after Cancer Surgery
    Surapaneni, Mihir
    Bonner, Sidra
    Nuliyalu, Ushapoorna
    Pizzo, Chelsea
    Nathan, Hari
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S255 - S255
  • [5] Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?
    Semiramis L. Carbajal-Mamani
    Bahram Dideban
    David Schweer
    Kristi T. Balavage
    Linus Chuang
    Yu Wang
    Shu Wang
    Ji-Hyun Lee
    Bernie Amaro
    Joel Cardenas-Goicoechea
    [J]. Journal of Robotic Surgery, 2021, 15 : 343 - 348
  • [6] Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?
    Carbajal-Mamani, Semiramis L.
    Dideban, Bahram
    Schweer, David
    Balavage, Kristi T.
    Chuang, Linus
    Wang, Yu
    Wang, Shu
    Lee, Ji-Hyun
    Amaro, Bernie
    Cardenas-Goicoechea, Joel
    [J]. JOURNAL OF ROBOTIC SURGERY, 2021, 15 (03) : 343 - 348
  • [7] Extended Venous Thromboembolism Prophylaxis After Cancer Surgery is Paradoxically Associated with a Higher Incidence of Venous Thromboembolism
    Fong, Zhi Ven
    Kartik, Akash
    Chang, Yu-Hui
    Stucky, Chee-Chee
    Mishra, Nitin
    Pockaj, Barbara A.
    Cronin, Patricia A.
    Linderman, George
    Potter, Alexandra
    Yang, Chi-Fu Jeffrey
    Wasif, Nabil
    Qadan, Motaz
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S242 - S243
  • [8] Extended Pharmacologic Prophylaxis for Venous Thromboembolism After Colon Cancer Surgery Is Associated With Improved Long-term Survival
    Booth, Alexander
    Brinton, Daniel
    Donahue, Colleen
    Westfal, Maggie
    George, Virgilio
    Maxwell, Pinckney J.
    Simpson, Kit
    Mahvi, David
    Curran, Thomas
    [J]. ANNALS OF SURGERY, 2024, 280 (04) : 595 - 603
  • [9] Extended venous thromboembolism prophylaxis after abdominopelvic cancer surgery: a retrospective review
    Laureano, M.
    Ebraheem, M.
    Crowther, M.
    [J]. CURRENT ONCOLOGY, 2019, 26 (01) : E106 - E110
  • [10] Is Extended Pharmacologic Venous Thromboembolism Prophylaxis Uniformly Safe After Radical Cystectomy?
    Mehrazin, Reza
    Piotrowski, Zachary
    Egleston, Brian
    Parker, Daniel
    Tomaszweski, Jeffrey J.
    Smaldone, Marc C.
    Abbosh, Philip H.
    Ito, Timothy
    Bloch, Paul
    Iffrig, Kevan
    Bilusic, Marijo
    Chen, David Y. T.
    Viterbo, Rosalia
    Greenberg, Richard E.
    Uzzo, Robert G.
    Kutikov, Alexander
    [J]. UROLOGY, 2014, 84 (05) : 1152 - 1156